Elevated TMAO levels have been linked to a number of diseases, including cardiovascular and neurological disorders, renal disease, metabolic syndrome, obesity, type 2 diabetes (T2D), non-alcoholic fatty liver disease (NAFLD), cancer, and severe COVID-19
Putting the trial numbers into perspective Historically, anti-obesity drugs produced average weight losses in the single digits (510%), and even the best options rarely approached double-digit percentages at the population level
Patients could obtain it with a valid prescription from their healthcare provider for a range of therapeutic purposes
Copper exposure: Because the molecule delivers copper, the long-term effect of repeated systemic copper-peptide dosing is unknown
To fully understand this, one needs to consider the mechanism of the methionine synthase reaction in relation to vitamin B12 and its various oxidation states
FAQs Which areas are treated